{
  "paper_metadata": {
    "pmid": "22632462",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8488-1G>A",
      "protein_notation": "p.Trp2830_Lys2833del",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Female, age 66-77",
        "phenotype": "Bilateral breast cancer at ages 66 and 74, ovarian cancer at age 77"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 77,
          "age_at_onset": 66,
          "age_at_diagnosis": 66,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Bilateral breast cancer and ovarian cancer",
          "evidence_sentence": "Variant c.8488-1G > A was detected in a patient who developed bilateral breast cancer at age 66 and 74 and ovarian cancer at age 77."
        }
      ],
      "functional_data": {
        "summary": "The variant affects the essential nucleotide -1 (G to A) of the acceptor splice site of BRCA2 exon 20, leading to aberrant splicing.",
        "assays": [
          "lymphocyte RT-PCR",
          "hybrid minigene assays"
        ]
      },
      "segregation_data": "The variant was found in a consanguineous Fanconi anemia patient.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was previously unreported in the BIC mutation database.",
      "key_quotes": [
        "This variant had not been reported at the BIC mutation database although it had formerly been found in a consanguineous Fanconi anemia patient.",
        "Altogether these data strongly support the pathogenicity of c.8488-1G > A."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.9026_9030del",
      "protein_notation": "p.Tyr3009SerfsX9",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Female, age not specified",
        "phenotype": "Not specified, but associated with breast/ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "uncertain",
          "phenotype_details": "Not specified",
          "evidence_sentence": "Lymphocyte RT-PCR of one carrier patient and we found the wt allele and the corresponding 5-nucleotide deletion transcript derived from the genomic variant (c.9026_9030del) without any splicing anomaly."
        }
      ],
      "functional_data": {
        "summary": "The variant is a deleterious frameshift mutation that would lead to a premature stop codon.",
        "assays": [
          "lymphocyte RT-PCR",
          "hybrid minigene assays"
        ]
      },
      "segregation_data": null,
      "population_frequency": "7.6% of BRCA2 families in Castilla y Le\u00f3n (Spain)",
      "evidence_level": "strong",
      "source_location": "Results, paragraph 5",
      "additional_notes": "It is one of the most prevalent mutations in the Spanish population.",
      "key_quotes": [
        "BRCA2 c.9026_9030del of exon 23 is a deleterious frameshift mutation that would lead to a premature stop codon.",
        "It is one of the most prevalent mutations in the Spanish population, accounting for 7.6% of BRCA2 families in Castilla y Le\u00f3n (Spain)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}